VERU INC. Current Federal, State and Local, Tax Expense (Benefit)
VERU INC. (VERU) reported Current Federal, State and Local, Tax Expense (Benefit) of $0 for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit · last filed 2024-12-16
- VERU INC. current federal, state and local, tax expense (benefit) for fiscal 2024 was $0.00.
- VERU INC. current federal, state and local, tax expense (benefit) for fiscal 2023 was -$8.62K.
| Period end | Current Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2024-09-30 | $0.00 10-K · filed 2024-12-16 |
| 2023-09-30 | -$8.62K 10-K · filed 2024-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |